Validation of an atrial fibrillation risk algorithm in Whites and African Americans

Archives of Internal Medicine

Volumn 170, Issue 21, 2010, Pages 1909-1917

  Schnabel, Renate B ^a,b   Aspelund, Thor ^c   Li, Guo ^d   Sullivan, Lisa M ^e   Suchy Dicey, Astrid ^e   Harris, Tamara B ⁱ   Pencina, Michael J ^b,e   D'Agostino Sr , Ralph B ^f,h   Levy, Daniel ^b,j   Kannel, William B ^b,g   Wang, Thomas J ^k   Kronmal, Richard A ^e   Wolf, Philip A ^b,g   Burke, Gregory L ^l   Launer, Lenore J ⁱ   Vasan, Ramachandran S ^b,g   Psaty, Bruce M ^d,e,m   Benjamin, Emelia J ^b,g   Gudnason, Vilmundur ^c   Heckbert, Susan R ^e,m  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b and Blood Institute   (United States)

^c UNIVERSITY OF ICELAND   (Iceland)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f BOSTON UNIVERSITY   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Boston University   (United States)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l WAKE FOREST SCHOOL OF MEDICINE   (United States)

^m CENTER FOR HEALTH STUDIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGE; AGED; ALGORITHM; ARTICLE; BODY MASS; EUROPEAN AMERICAN; FEMALE; FRAMINGHAM HEART STUDY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PR INTERVAL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX; SYSTOLIC BLOOD PRESSURE; VALIDATION STUDY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; AGED, 80 AND OVER; ALGORITHMS; ATRIAL FIBRILLATION; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; ELECTROCARDIOGRAPHY; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; SYSTOLE; UNITED STATES;

EID: 78649665827     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.434     Document Type: Article

References (24)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-2375.
2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119-125.
3. Benjamin EJ, Chen PS, Bild DE, et al. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation. 2009;119(4):606-618.
4. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373(9665):739-745.
5. Borzecki AM, Bridgers DK, Liebschutz JM, Kader B, Kazis LE, Berlowitz DR. Racial differences in the prevalence of atrial fibrillation among males. J Natl Med Assoc. 2008;100(2):237-245.
6. Bush D, Martin LW, Leman R, Chandler M, Haywood LJ; NHLBI AFFIRM Investigators. Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. J Natl Med Assoc. 2006;98(3):330-339.
7. Harris TB, Launer LJ, Eiriksdottir G, et al. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol. 2007;165(9):1076-1087. (Pubitemid 46598837)
8. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
9. Schellenbaum GD, Heckbert SR, Smith NL, et al. Congestive heart failure incidence and prognosis: case identification using central adjudication versus hospital discharge diagnoses. Ann Epidemiol. 2006;16(2):115-122.
10. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88(1):107-115.
11. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9(12):1501-1515.
12. D'Agostino RB Sr, Grundy S, Sullivan LM,Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180-187.
13. D'Agostino RB, Nam BH. Evaluation of the performance of survival analysis models: discrimination and calibration measures. In: Balakrishnan N, Rao CR, eds. Handbook of Statistics. Amsterdam, the Netherlands: Elsevier; 2004:1-25.
14. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health. 2001;55(7):508-514.
15. Alonso A, Agarwal SK, Soliman EZ, et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009;158(1):111-117.
16. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96(7):2455-2461. (Pubitemid 27425856)
17. Marrugat J, D'Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003;57(8):634-638.
18. Liu J, Hong Y, D'Agostino RB Sr, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004;291(21):2591-2599.
19. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271(11):840-844. (Pubitemid 24076851)
20. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-up Study. Am J Med. 1995;98(5):476-484.
21. Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DC Jr. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2009;40(4):1204-1211.
22. Turgut O, Tandogan I, Yilmaz MB, Yalta K, Aydin O. Association of P wave duration and dispersion with the risk for atrial fibrillation: Practical considerations in the setting of coronary artery disease [published online March 13, 2009]. Int J Cardiol. doi:10.1016/j.ijcard.2009.03.023.
23. Darbar D, Hardy A, Haines JL, Roden DM. Prolonged signal-averaged P-wave duration as an intermediate phenotype for familial atrial fibrillation. J Am Coll Cardiol. 2008;51(11):1083-1089.
24. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52(5):818-827.